ReviewFrontiers in cellular neuroscience2026
Developmental stage-dependent neurotoxicity of sevoflurane: evidence from brain organoids.
Review in Frontiers in cellular neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioengineered human brain organoids and organ-on-chip platforms for exposure-aware assessment of developmental neurotoxicity induced by general anesthetics and sedatives.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sevoflurane is widely used in pediatric anesthesia because it allows rapid induction and recovery, yet its use during vulnerable periods of brain development has raised concerns about long-term neurocognitive effects. Experimental data indicate that sevoflurane engages multiple interacting pathways, including mitochondrial dysfunction, oxidative and iron-dependent injury, and immune-mediated synaptic and inflammatory responses, whose net impact depends on dose, timing, and exposure duration. Human brain organoids have meanwhile emerged as human-based three-dimensional models that reproduce key aspects of cortical and midbrain development and permit clinically relevant exposure paradigms to be tested
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.